SANUWAVE Health, Inc.
SNWV
$29.89
-$1.06-3.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.50% | 59.99% | 55.01% | 37.42% | 29.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.50% | 59.99% | 55.01% | 37.42% | 29.35% |
| Cost of Revenue | 33.05% | 33.95% | 57.09% | 47.10% | 35.11% |
| Gross Profit | 72.77% | 70.94% | 54.25% | 33.92% | 27.21% |
| SG&A Expenses | 31.14% | 30.21% | 2.40% | -12.20% | -29.46% |
| Depreciation & Amortization | 7.25% | 4.92% | 0.40% | -2.38% | -4.36% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.51% | 30.00% | 15.60% | 1.45% | -16.27% |
| Operating Income | 1,815.94% | 1,105.01% | 229.37% | 129.03% | 104.33% |
| Income Before Tax | -88.35% | -21.48% | 99.23% | 87.39% | 5.58% |
| Income Tax Expenses | 575.00% | 575.00% | 100.00% | 100.00% | 100.00% |
| Earnings from Continuing Operations | -88.47% | -21.56% | 99.22% | 87.37% | 5.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.47% | -21.56% | 99.22% | 87.37% | 5.57% |
| EBIT | 1,815.94% | 1,105.01% | 229.37% | 129.03% | 104.33% |
| EBITDA | 563.76% | 1,225.15% | 343.02% | 159.41% | 116.27% |
| EPS Basic | 34.22% | 56.78% | 100.80% | 81.63% | 15.82% |
| Normalized Basic EPS | 15.81% | 46.36% | 94.65% | 72.11% | 14.06% |
| EPS Diluted | 31.15% | 54.98% | 99.66% | 80.40% | 21.72% |
| Normalized Diluted EPS | 15.22% | 46.01% | 94.44% | 71.77% | 17.56% |
| Average Basic Shares Outstanding | 132.26% | 110.86% | 77.96% | 90.58% | 67.56% |
| Average Diluted Shares Outstanding | 137.71% | 117.32% | 85.78% | 99.54% | 45.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |